Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 380 (MIR380) is a small, non-coding RNA (~20-24 nucleotides) of the microRNA family, encoded within the human genome as an ncRNA gene. It is involved in the post-transcriptional regulation of gene expression, usually by binding to complementary sequences in the 3′ untranslated region (UTR) of messenger RNAs, leading to their silencing either through translational inhibition or mRNA destabilization. In specific contexts, miR-380-3p suppresses translation of the Sp3 transcription factor, which contributes to cell proliferation inhibition and apoptosis induction in neural cells, and enhances neurotoxic effects induced by paraquat exposure. MIR380 expression is linked to various diseases, particularly cancers of the nervous system and potentially other neurological conditions. Therapeutically, while miRNAs like MIR380 are attractive molecular targets, there are currently no approved drugs targeting this miRNA; experimental approaches utilize oligonucleotide mimics or inhibitors to study or modulate its activity.
Synthetic miR-380-3p mimics repress translation of target mRNA, such as Sp3 transcription factor, leading to cell proliferation inhibition and increased apoptosis. Inhibitors block miR-380-3p activity, potentially permitting higher expression of targets like Sp3.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 380 (MIR380).